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Classic renal angiomyolipoma (AML) is one of the
most common benign renal lesions of the kidney,
comprising 2.0–6.4% of all renal tumors [1]. In 
most cases, AML follows a benign course and has
clearly defined radiological and histological charac-
teristics. Rare cases of clinically aggressive or malig-
nant AML, which is histologically categorized as
epithelioid AML (EAML), have been reported.
EAML is highly cellular, composed of atypical
epithelioid cells, and has no or a minimal amount of
fat tissue, which often resemble renal cell carcinomas
(RCC) both radiographically and histologically. We
describe five cases of EAML to illustrate the spec-
trum of clinicopathological features and we review
the literature.
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Classical renal angiomyolipoma (AML) is a common tumor that, in most cases, follows a benign
course and has clearly defined radiologic and histological characteristics. However, rare cases of
clinically aggressive or malignant AML, the epithelioid variant of AML (EAML), have been
reported. Here, we review the five cases of EAML diagnosed since 2000 at our institution to high-
light the spectrum of clinical, radiological and histological characteristics. In all cases, renal
lesions seen on computed tomography (CT) were considered as suspicious for renal cell carci-
noma (RCC) without tumor extension or metastasis. One of the two patients with definitive
tuberous sclerosis complex had a small conventional AML with fat content in the other kidney.
Histologically, these tumors can resemble sarcomatoid RCC or high grade RCC. The final diagno-
sis is established by the presence of perivascular epithelioid cells and immunohistochemistry
markers. There was no evidence of local recurrence or metastatic disease found by sonography,
CT and magnetic resonance imaging during the follow-up period. EAMLs are capable of aggres-
sive or malignant clinical behavior. Approximately one third of the reported EAMLs show
advanced disease; therefore, we recommend that it is important to treat and closely follow-up
such cases, similar to that for RCC, because of its malignant potential.
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METHODS
Between January 2000 and December 2007, five pa-
tients were diagnosed with EAML at our institution.
All medical records were reviewed and summarized.
Renal tumors were staged according to the American
Joint Committee on Cancer staging manual. Preoper-
ative staging evaluation included computed tomog-
raphy (CT) of the abdomen/pelvis, chest X-rays and
a complete metabolic profile. Table 1 lists the anti-
bodies used for the immunohistochemical analysis.
Immunohistochemical analysis was performed using
appropriate positive and negative controls. Formalin-
fixed, paraffin-embedded samples were stained by
immunohistochemistry using the avidin-biotin-per-
oxidase complex.
RESULTS
Table 2 summarizes the patient characteristics. All
five patients had isolated heterogeneous renal masses
Table 1. Antibodies used for immunohistochemical analysis
Antibody Clone Dilution Pretreatment Source
Melanoma Monoclonal HMB-45 1:100 None Biogenex
Cytokeratin Monoclonal AE1/AE3 1:50 Heat—5 min Dako
S100 Polyclonal 1:1,600 Trysin—10 min Dako
Smooth muscle actin Monoclonal 1A4 1:50 None Biogenex
Muscle actin Monoclonal HHF-35 1:100 None Dako
Table 2. Clinical characteristics of patients diagnosed with epithelioid angiomyolipoma
Case 1 Case 2 Case 3 Case 4 Case 5
Age (yr) 42 32 52 37 35
Sex Female Male Female Male Male
TSC Yes No Yes No No
Renal lesion
Symptomatic No Yes* NO No No
Size 5 cm 7.3 cm 3 cm 2.6 cm 6.8 cm
Location Left low Left middle Right middle Left lower Left upper
Fat densities (CT finding) No No No† No No
Necrosis No Yes No No No
Hemorrhage Yes Yes No No No
Tumor thrombus No No No No No
Local advance or distal No No No No No
metastasis
Lymph node adenopathy No No No No No
Surgical procedure Nephrectomy Nephrectomy Laparoscopic Nephrectomy Nephrectomy
partial 
nephrectomy
TNM stage T1bN0M0 T2aN0M0 T1aN0M0 T1aN0M0 T1bN0M0
Immunohistochemistry
HMB-45 Positive Positive Positive Positive Positive
Cytokeratin Negative Negative Negative Negative Negative
S100 Negative Negative Negative Negative Negative
Time to recurrence/length −/80 −/36 −/1‡ −/1 −/11
of follow-up (mo)
Status Alive Alive Lost to follow-up Alive Alive
*Symptoms resulted from hemorrhage into a 7.3 cm renal lesion; †she had a small conventional angiomyolipoma with fat content on
the other side of kidney; ‡we lost follow-up for case 3 who had bilateral renal AML because she moved to a foreign country.
noted on CT scan. None of the lesions contained fat
components (−20 HU) or calcification (Figure 1),
but one lesion showed central hemorrhage and necro-
sis (Case 2). There were no instances of lymphadenop-
athy or venous invasion. These masses showed good
enhancement in the post-contrast arterial portal phase.
One (Case 3) of the two patients with definitive
tuberous sclerosis complex (TSC) had a small con-
ventional AML with fat content in the other kidney
(Figure 2). Because all of the lesions were considered
as suspicious for RCC, all of the patients received
surgical intervention (radical or partial nephrectomy
with/without laparoscopic method) and close follow-
up (1–80 months). No patient had local recurrence 
or distal metastasis on sonography, CT and magnetic
resonance imaging (MRI) during the follow-up period.
Because the tumor lesion of Case 3 who had stage 3
chronic kidney disease and bilateral renal AML had 
a diameter of less than 4 cm and the peripheral loca-
tion was without advanced invasion, we performed
nephron-sparing surgery with laparoscopic partial
nephrectomy. However, she went abroad and was
lost to follow-up 1 month after surgery.
The histological diagnosis of these renal tumors was
EAML based on microscopic findings and immuno-
histochemical markers. On the cut surface, the tumors
showed a brown and friable extent from the renal pa-
renchyma with or without focal necrosis (Figure 3A).
Proliferation of epithelioid cells (PEC) with abundant
granular cytoplasm was noted (Figure 3B) in all cases
on microscopic examination. These tumor cells had
enlarged vesicular nuclei and prominent nucleoli with
nuclear anaplasia and mitotic appearance. The main
differential diagnoses based on histological charac-
teristics included sarcomatoid RCC, high grade RCC,
metastatic melanoma and EAML. Therefore, we used
immunohistochemical markers to rule out RCC and
melanoma; the absence of staining for epithelial
markers such as cytokeratin made RCC unlikely
(Figure 3C). We also ruled out melanoma because 
of negative staining for melanoma markers such as
S100. The final diagnosis was confirmed by positive
EAML of the kidney mimicking RCC
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Figure 1. Case 4. A 2.9 × 2.7 × 3.3 cm slightly hypodense and
mildly hypervascular nodule was noted, bulging outward from
the left renal parenchyma. The left renal tumor was noted acci-
dentally by sonography during a health check-up.
A B
Figure 2. Computed tomography scan of a patient with tuberous sclerosis complex (Case 3). (A) An enhanced right renal mass devoid
of fat densities and considered suspicious for renal cell carcinoma. (B) The renal lesion in the left kidney was characterized by conven-
tional angiomyolipomas.
staining for smooth muscle actin (SMA) and mono-
clonal HMB-45 (Figure 3D).
DISCUSSION
Typical AML comprises a mixture of mature adipose
tissue, smooth muscle cells and thick-walled blood
vessels. The components of AML are thought to arise
from unsuppressed and aberrant differentiation of re-
nal mesenchyme, belonging to the group of PEComas,
tumors derived from perivascular epithelioid cells. 
In 1996, Zamboni et al proposed a modulation scheme
encompassing the morphologic-immunophenotypic
variability in tumors composed of PEC, including
AML, lymphangioleiomyomas, and clear cell “sugar”
tumors of the lung and pancreas [2]. AML can occur
as an isolated renal lesion, being solitary and large, or
as part of hereditary diseases, most commonly TSC,
and are then often small, bilateral and multifocal [3].
Although approximately 50% of patients with TSC
develop AML, 90% of renal AMLs are sporadic and
unrelated to TSC [4].
Renal AMLs have clearly defined radiological and
histological characteristics. On unenhanced CT, lesions
with low fat and no calcification are diagnostic for
AML [5], and we recommend an algorithm for radio-
logical diagnosis (Figure 4). MRI is useful when other
imaging is equivocal or for evaluation during preg-
nancy. It is sometimes difficult to differentiate AML
with minimal fat from RCC. Kim et al identified
some characteristics specific of AML with minimal
fat, including homogeneous enhancement, prolonged
enhancement pattern, high tumor attenuation on
unenhanced scans and less mean enhancement [6].
The diagnosis of AML can usually be established by
imaging alone, but CT-guided percutaneous biopsy
(2–5 cores), which has a high diagnostic accuracy in
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Figure 3. Case 4. (A) The gross cut surface of the tumors showed a brown and friable extent from the renal parenchyma. (B) Epithelioid
angiomyolipoma (AML) is distinguished from conventional AML by the presence of highly cellular and large epithelioid cells, which have
abundant eosinophilic cytoplasm (hematoxylin & eosin). (C) Neoplastic cells show no cytoplasmic immunoreactivity to cytokeratin.
(D) Neoplastic cells show strong cytoplasmic granular immunoreactivity to HMB-45.
predicting malignancy, is sometimes necessary if RCC
is suspected, particularly for small renal tumors of less
than 4 cm in size [5,7].
In most cases, AML is asymptomatic and follows
a benign course. However, rare cases of clinically
aggressive or malignant AML have been reported.
These atypical variants of AML are histologically cat-
egorized as EAML. We review the case series (more
than 2 patients) of EAML since 1998 in Table 3 [3,8–12].
There are 22 patients in this summary and most of
them have no fat components in the image survey.
All EAMLs were positive for melanoma markers
(HMB-45). The rate of metastasis or recurrence seems
to be directly proportional to the size of the primary
renal mass. Approximately one third of patients with
EAML present with extension into the perirenal soft
tissue and vena cava, and local recurrence and distant
metastasis, such as lymph node, lung, liver or spinal
cord metastasis [3,13,14]. However, it is important to
recognize that EAML can develop adjacent to or even
within conventional AML [12,15].
EAML often resembles sarcomatoid RCC or high-
grade RCC both radiographically and histologically.
Under gross examination, EAML usually shows a
brown and friable extent from the renal parenchyma
with or without focal necrosis. On the other hand, con-
ventional RCC usually has a bright yellow cut sur-
face. Histologically, EAML is solid, highly cellular, with
occasional microcysts, composed of medium to large
epithelioid cells with clear or eosinophilic cytoplasm.
There are also some short spindle cells and numerous
giant multinucleated cells [16]. Adipose tissue, smooth
muscle and thick-walled vascular elements are usu-
ally absent in EAMLs. We were unable to find any
reports related to EAML with fat densities noted on
CT or MRI. Pea et al reviewed five tumors that were
previously reported as RCC in patients with TSC, and
three of the tumors were reclassified as EAML. Their
study suggests that the increased incidence of RCC
associated with TSC may be due to incorrect classifi-
cation of EAML as RCC [9]. Therefore, further studies
are needed to determine the true incidence of EAML;
however, five cases of EAML were diagnosed at our
institution during an 84-month period, suggesting
that EAML is not uncommon. Approximately half of
published cases of EAML have a history of TSC [1];
therefore, diagnosis of EAML should be considered
in patients diagnosed with sarcomatoid RCC, partic-
ularly if the patient has clinical stigmata of TSC.
Because EAML can resemble sarcomatoid RCC
and metastatic melanoma, the final diagnosis is estab-
lished based on the presence of immunohistochem-
istry markers. Immunoreactivity for HMB-45 antigen,
a melanosome-associated protein, has been demon-
strated in renal AML. The recognition that AML is
uniformly positive for melanoma markers (HMB-45
and melan-A) and smooth muscle markers (HHF-35,
SMA and caldesmon) has facilitated correct diagnosis
[17]. Of note, all renal AMLs were negative for S100
and cytokeratin. As a classic AML, most EAMLs 
EAML of the kidney mimicking RCC
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Hyperechoic renal mass
Contrast CT
Fat (< −20 HU) No fat (> −20 HU)
Thin sections (≤ 5 mm)
Fat (< −20 HU) No fat (> −20 HU)
AML: Less likely
AML: More likely
• Calcifications or necrosis
 with small foci of fat
• Large, irregular tumor
 invading perirenal fat
• Lymph nodes or venous
 invasion
• Growth > 0.5 cm per year
Yes
No
Figure 4. An algorithm for radiological diagnosis of renal angiomyolipoma.
have the same immunohistochemistry characteristics.
Therefore, the histological diagnosis of EAML can be
confirmed by evaluating the expression of immuno-
histochemical marker.
Approximately one third of EAMLs present with
aggressive behavior or metastasis; therefore, surgical
resection has become the gold standard therapy for
localized EAML. Nevertheless, it is important to con-
tinue to follow-up the cases after surgery, as for RCC.
However, as mentioned above, EAML is part of the
perivascular epithelioid cell tumors (PEComa) family
and is considered chemosensitive. Metastatic EAML
has been treated with a variety of chemotherapeutic
agents including doxorubicin, dacarbazine, ifosfamide,
cyclophosphamide and cisplatin [3]. However, long-
term efficacy and the most effective agent remain to
be determined. Surgery seems to yield beneficial out-
comes for aggressive EAML [2]. Further studies in
this regard and long-term follow-up of patients after
surgery will help establish a standard for treatment
and follow-up.
EAMLs may occur sporadically or as part of TSC.
They often resemble RCC radiographically and histo-
logically, and can be locally aggressive and metasta-
tic. These tumors are distinguished from RCC not only
by identifying epithelioid cells within the tumor, but
also by immunostaining (positive for HMB45 and
negative for cytokeratin and S100). Because approxi-
mately one third of cases of EAML show advanced
disease, it is essential to initiate appropriate treat-
ment with close follow-up, as for RCC, owing to its
malignant potential.
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與腎細胞癌相似之類上皮腎臟血管肌肉脂肪瘤 
— 病例分析回顧
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典型腎臟血管肌肉脂肪瘤為常見腫瘤，大多呈現良性病灶且有典型影像及病理學特
徵。但少數類上皮腎臟血管肌肉脂肪瘤於臨床有惡性表現。我們回顧自 2000 年以來
在高雄醫學大學附設中和紀念醫院中所診斷的五位類上皮腎臟血管肌肉脂肪瘤病例。
所有病人經電腦斷層掃描均被診斷為腎細胞癌且沒有其他系統性的轉移。組織切片的
結果顯示腫瘤細胞與高度未分化惡性肉瘤腎細胞癌相似。最終診斷依靠發現類上皮細
胞的存在及免疫組織化學的標示。手術後在持續追蹤之下，並沒有疾病復發。類上皮
腎臟血管肌肉脂肪瘤可能於臨床有惡性表現。此種腫瘤須靠組織切片的成像及免疫組
織化學的標示來與惡性腎細胞癌作鑑別診斷。經統計近三分之一的類上皮腎臟血管肌
肉脂肪瘤有有惡性表現，故對於此種腫瘤所採取的治療及追蹤方式應和腎細胞癌相
似。
關鍵詞：類上皮變化，腎臟血管肌肉脂肪瘤
(高雄醫誌 2009;25:133–40)
